Managing patient adherence and quality of life in epilepsy

por Eatock, Joanne, Baker, Gus A
Publicado 2007

Uses and abuses of the neuropsychological assessment in the presurgical evaluation of epilepsy surgery candidates

por Baxendale, Sallie, Baker, Gus A.
Publicado 2021

Self-reported feelings of anger and aggression towards others in patients on levetiracetam: data from the UK antiepileptic drug register

por Wieshmann, Udo Carl, Baker, Gus A
Publicado 2013

Patient‐Focused Drug Development Methods for Benefit–Risk Assessments: A Case Study Using a Discrete Choice Experiment for Antiepileptic Drugs

por Holmes, Emily A.F., Plumpton, Catrin, Baker, Gus A., Jacoby, Ann, Ring, Adele, Williamson, Paula, Marson, Anthony, Hughes, Dyfrig A.
Publicado 2018

NRSF and BDNF polymorphisms as biomarkers of cognitive dysfunction in adults with newly diagnosed epilepsy

por Warburton, Alix, Miyajima, Fabio, Shazadi, Kanvel, Crossley, Joanne, Johnson, Michael R., Marson, Anthony G., Baker, Gus A., Quinn, John P., Sills, Graeme J.
Publicado 2016

European Clinical Neuropsychology: Role in Healthcare and Access to Neuropsychological Services

por Kasten, Erich, Barbosa, Fernando, Kosmidis, Mary H., Persson, Bengt A., Constantinou, Marios, Baker, Gus A., Lettner, Sandra, Hokkanen, Laura, Ponchel, Amélie, Mondini, Sara, Jonsdottir, Maria K., Varako, Nataliya, Nikolai, Tomas, Pranckeviciene, Aiste, Harper, Lauren, Hessen, Erik
Publicado 2021

The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, mult...

por Marson, Anthony, Burnside, Girvan, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin, Plumpton, Catrin, Hughes, Dyfrig A, Williamson, Paula, Baker, Gus A, Balabanova, Silviya, Taylor, Claire, Brown, Richard, Hindley, Dan, Howell, Stephen, Maguire, Melissa, Mohanraj, Rajiv, Smith, Philip E
Publicado 2021

The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inf...

por Marson, Anthony, Burnside, Girvan, Appleton, Richard, Smith, Dave, Leach, John Paul, Sills, Graeme, Tudur-Smith, Catrin, Plumpton, Catrin, Hughes, Dyfrig A, Williamson, Paula, Baker, Gus A, Balabanova, Silviya, Taylor, Claire, Brown, Richard, Hindley, Dan, Howell, Stephen, Maguire, Melissa, Mohanraj, Rajiv, Smith, Philip E
Publicado 2021